{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:25:27Z","timestamp":1777429527992,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jcv.2021.105064","type":"journal-article","created":{"date-parts":[[2022,1,2]],"date-time":"2022-01-02T09:37:02Z","timestamp":1641116222000},"page":"105064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A quantitative assay for detection of SARS-CoV-2 neutralizing antibodies"],"prefix":"10.1016","volume":"147","author":[{"given":"Helena","family":"Cerutti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Bandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinunzia","family":"Castria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Cartocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Tornesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Bogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Tesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Soldatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Toppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Brogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2021.105064_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-020-00711-w","article-title":"Antibodies, epicenter of SARS-CoV-2 immunology","volume":"28","author":"Pecetta","year":"2021","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jcv.2021.105064_bib0002","doi-asserted-by":"crossref","DOI":"10.1111\/trf.16261","article-title":"Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors","volume":"61","author":"Annen","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.jcv.2021.105064_bib0003","doi-asserted-by":"crossref","DOI":"10.1007\/s11427-020-1859-y","article-title":"Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?","volume":"63","author":"Lu","year":"2020","journal-title":"Sci. China Life Sci"},{"key":"10.1016\/j.jcv.2021.105064_bib0004","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41392-021-00686-1","article-title":"SARS-CoV-2-specific immune response in COVID-19 convalescent individuals","volume":"6","author":"Pan","year":"2021","journal-title":"Signal Transduct. Target Ther"},{"key":"10.1016\/j.jcv.2021.105064_bib0005","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2026116","article-title":"Humoral immune response to SARS-CoV-2 in Iceland","volume":"383","author":"Gudbjartsson","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jcv.2021.105064_bib0006","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc1227","article-title":"Serology assays to manage COVID-19","volume":"368","author":"Krammer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jcv.2021.105064_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med"},{"key":"10.1016\/j.jcv.2021.105064_bib0008","doi-asserted-by":"crossref","first-page":"450","DOI":"10.7326\/M20-2854","article-title":"Serodiagnostics for severe acute respiratory syndrome-related coronavirus 2: a narrative review","volume":"173","author":"Cheng","year":"2020","journal-title":"Ann. Intern. Med"},{"key":"10.1016\/j.jcv.2021.105064_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104511","article-title":"Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)","volume":"129","author":"Nicol","year":"2020","journal-title":"J. Clin. Virol"},{"key":"10.1016\/j.jcv.2021.105064_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104540","article-title":"Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays","volume":"129","author":"Weidner","year":"2020","journal-title":"J. Clin. Virol"},{"key":"10.1016\/j.jcv.2021.105064_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23735","article-title":"Large scale production and characterization of SARS-CoV-2 whole antigen for serological test development","volume":"35","author":"Cerutti","year":"2021","journal-title":"J. Clin. Lab. Anal"},{"key":"10.1016\/j.jcv.2021.105064_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.02.035","article-title":"Extremely potent human monoclonal antibodies from COVID-19 convalescent patients","volume":"184","author":"Andreano","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jcv.2021.105064_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.12.024","article-title":"Emergence of a new SARS-CoV-2 variant in the UK","volume":"82","author":"Tang","year":"2021","journal-title":"J. Infect"},{"key":"10.1016\/j.jcv.2021.105064_bib0014","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103154118","article-title":"SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma","volume":"118","author":"Andreano","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.jcv.2021.105064_bib0015","unstructured":"WHO. Available at: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/standardization-of-vaccines-for-coronavirus-disease-covid-19. Accessed 3 Sep, 2021."},{"key":"10.1016\/j.jcv.2021.105064_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat. Med"},{"key":"10.1016\/j.jcv.2021.105064_bib0017","article-title":"Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis","volume":"370","author":"Lisboa Bastos","year":"2020","journal-title":"BMJ"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653221003310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653221003310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:16:10Z","timestamp":1761362170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653221003310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":17,"alternative-id":["S1386653221003310"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2021.105064","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A quantitative assay for detection of SARS-CoV-2 neutralizing antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2021.105064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105064"}}